ArticleGenes & diseases2024

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567].

Wan-Xin Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.